ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.32
-0.01
-2.02%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.59
-0.12
-4.43%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
ACAD
41.57
-0.12
-0.29%
AEMD
6.75
-0.15
-2.17%
APRI
1.87
+0.02
+1.08%
ARNA
4.52
+0.08
+1.80%
ATEC
1.36
-0.03
-2.16%
CNAT
5.02
-0.14
-2.71%
CRXM
0.32
-0.01
-2.02%
CYTX
0.53
-0.018
-3.2505%
DXCM
79.71
+0.35
+0.44%
GNMK
8.97
+0.06
+0.67%
HALO
22.78
+0.68
+3.08%
ILMN
220.51
+0.44
+0.20%
INNV
0.12
0.00
0.00%
INO
7.87
-0.05
-0.63%
ISCO
0.048
+0.005
+10.4651%
ISIS
55.43
-0.7
-1.25%
LGND
98.93
+0.33
+0.33%
LPTN
0.256
-0.019
-6.9793%
MBVX
2.59
-0.12
-4.43%
MEIP
1.74
-0.03
-1.69%
MNOV
3.94
-0.08
-1.99%
MRTX
31.85
+0.55
+1.76%
MSTX
0.462
-0.018
-3.7708%
NBIX
48.32
+1.01
+2.13%
NUVA
47.49
+0.2
+0.42%
ONCS
6.12
-0.23
-3.62%
ONVO
3.73
-0.01
-0.27%
OREX
4.77
+0.01
+0.21%
OTIC
22.06
-0.03
-0.14%
QDEL
22.8
-0.21
-0.91%
RCPT
198.25
+3.34
+1.71%
RGLS
10.32
+0.12
+1.18%
RMD
55.38
+0.07
+0.13%
SCIE
0.015
-0.002
-9.3750%
SPHS
0.8
-0.02
-2.79%
SRNE
17.29
+0.61
+3.66%
TROV
10.1
+0.57
+5.98%
VICL
0.7
0.00
+0.01%
ZGNX
13.03
+0.23
+1.80%
Home » Archive by Author

Articles by Sandeep Pingle

Future of Cancer Therapeutics: #BIO2014

June 25, 2014 – 7:29 am

It has been four decades since the initiation of President Nixon’s “War on Cancer”, but never have the signs for victory looked so encouraging. This is an exciting phase in cancer research, so much so …

Bioethics in Drug Development: BIO2014

June 24, 2014 – 6:52 am

Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical …

Bioethics of Compassionate Use of Drugs: BIO2014

June 24, 2014 – 6:51 am

BIO2014 begins! The much-awaited 2014 BIO International Convention kicked off with a day of special sessions on Monday, June 23rd, 2014.
via Bioethics of Compassionate Use of Drugs: BIO2014.

Protein-Protein Interactions and Cancer

May 15, 2014 – 6:39 am

Protein-protein interactions (PPI) are key regulatory processes in cancer because many proteins that directly interact with binding partners regulate tumor growth. Recognizing this role of PPIs, they have been the focus of recent drug development/discovery …

Targeting Protein-Protein Interactions For Drug Discovery

May 15, 2014 – 6:07 am

Cambridge Healthtech Institute (CHI) organizes the annual Drug Discovery Chemistry (DDC) conference that focuses on drug discovery of small molecule candidates and challenges involved in their optimization. True to its motto “Optimizing Small Molecules For …